Back
Defiance Nasdaq 100 Income Target ETF Vs. Corcept Therapeutics Industry Stock Comparison
Sell
23
QQQT
Defiance Nasdaq 100 Income Target ETF
Last Price:
19.18
Seasonality Move:
--
Buy
74
CORT
Corcept Therapeutics
Last Price:
40.92
Seasonality Move:
-0.77%
Sell
23
Defiance Nasdaq 100 Income Target ETF (QQQT)
is a Sell
Is Defiance Nasdaq 100 Income Target ETF a Buy, Sell or Hold?
- The current Defiance Nasdaq 100 Income Target ETF [QQQT] share price is $19.19. The Score for QQQT is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- QQQT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $40.92. The Score for CORT is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
QQQT Stock Price Chart
What is Defiance Nasdaq 100 Income Target ETF's stock price today?
-
The Defiance Nasdaq 100 Income Target ETF share price today is $19.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QQQT is experiencing slight selling pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $40.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing selling pressure, which indicates risk of future bearish movement.
QQQT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 57.35 | Buy |
Chaikin Money Flow: | -3276 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.43 - 19.35) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
CORT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.55 | Buy |
Relative Strength Index (14 RSI): | 72.34 | Buy |
Chaikin Money Flow: | -986948 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.51 - 37.97) | Buy |
Bollinger Bands (100): | (28.35 - 36.03) | Buy |
QQQT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.75 | Buy |
20-day SMA: | 18.76 | Buy |
50-day SMA: | 18.97 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 18.79 | Buy |
20-day EMA: | 18.77 | Buy |
50-day EMA: | 10.66 | Buy |
200-day EMA: | 3.56 | Buy |
CORT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.22 | Buy |
20-day SMA: | 36.07 | Buy |
50-day SMA: | 35.08 | Buy |
200-day SMA: | 28.51 | Buy |
8-day EMA: | 38.83 | Buy |
20-day EMA: | 36.86 | Buy |
50-day EMA: | 34.93 | Buy |
200-day EMA: | 30.16 | Buy |
Defiance Nasdaq 100 Income Target ETF Earnings Growth & QQQT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.15 per share, an increase this year of $0.22 per share, and an increase next year of $0.59 per share.
Defiance Nasdaq 100 Income Target ETF Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corcept Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |